Global Therapeutic Radioisotopes Sales Market Report 2021

1 Therapeutic Radioisotopes Market Overview

• 1.1 Therapeutic Radioisotopes Product Scope
• 1.2 Therapeutic Radioisotopes Segment by Type
  • 1.2.1 Global Therapeutic Radioisotopes Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Radium-223
  • 1.2.3 Lutetium-177
  • 1.2.4 Iodine-131
  • 1.2.5 Other
• 1.3 Therapeutic Radioisotopes Segment by Application
  • 1.3.1 Global Therapeutic Radioisotopes Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Thyroid
  • 1.3.3 Bone Metastasis
  • 1.3.4 Lymphoma
  • 1.3.5 Other
• 1.4 Therapeutic Radioisotopes Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Therapeutic Radioisotopes Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Therapeutic Radioisotopes Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Therapeutic Radioisotopes Price Trends (2016-2027)

2 Therapeutic Radioisotopes Estimates and Forecasts by Region

• 2.1 Global Therapeutic Radioisotopes Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Therapeutic Radioisotopes Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Therapeutic Radioisotopes Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Region (2016-2021)
• 2.3 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Therapeutic Radioisotopes Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Therapeutic Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.2 Europe Therapeutic Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.3 China Therapeutic Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.4 Japan Therapeutic Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Therapeutic Radioisotopes Estimates and Projections (2016-2027)
  • 2.4.6 India Therapeutic Radioisotopes Estimates and Projections (2016-2027)

3 Global Therapeutic Radioisotopes Competition Landscape by Players

• 3.1 Global Top Therapeutic Radioisotopes Players by Sales (2016-2021)
• 3.2 Global Top Therapeutic Radioisotopes Players by Revenue (2016-2021)
• 3.3 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2020)
• 3.4 Global Therapeutic Radioisotopes Average Price by Company (2016-2021)
• 3.5 Manufacturers Therapeutic Radioisotopes Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Therapeutic Radioisotopes Market Size by Type

• 4.1 Global Therapeutic Radioisotopes Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Therapeutic Radioisotopes Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Therapeutic Radioisotopes Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Therapeutic Radioisotopes Price by Type (2016-2021)
• 4.2 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Therapeutic Radioisotopes Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Therapeutic Radioisotopes Price Forecast by Type (2022-2027)

5 Global Therapeutic Radioisotopes Market Size by Application

• 5.1 Global Therapeutic Radioisotopes Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Therapeutic Radioisotopes Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Therapeutic Radioisotopes Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Therapeutic Radioisotopes Price by Application (2016-2021)
• 5.2 Global Therapeutic Radioisotopes Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Therapeutic Radioisotopes Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Therapeutic Radioisotopes Price Forecast by Application (2022-2027)

6 North America Therapeutic Radioisotopes Market Facts & Figures

• 6.1 North America Therapeutic Radioisotopes Sales by Company
  • 6.1.1 North America Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 6.1.2 North America Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 6.2 North America Therapeutic Radioisotopes Sales Breakdown by Type
  • 6.2.1 North America Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 6.3 North America Therapeutic Radioisotopes Sales Breakdown by Application
  • 6.3.1 North America Therapeutic Radioisotopes Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Therapeutic Radioisotopes Sales Breakdown by Application (2022-2027)

7 Europe Therapeutic Radioisotopes Market Facts & Figures

• 7.1 Europe Therapeutic Radioisotopes Sales by Company
  • 7.1.1 Europe Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 7.1.2 Europe Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 7.2 Europe Therapeutic Radioisotopes Sales Breakdown by Type
  • 7.2.1 Europe Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 7.3 Europe Therapeutic Radioisotopes Sales Breakdown by Application
  • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Therapeutic Radioisotopes Market Facts & Figures

• 8.1 China Therapeutic Radioisotopes Sales by Company
  • 8.1.1 China Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 8.1.2 China Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 8.2 China Therapeutic Radioisotopes Sales Breakdown by Type
  • 8.2.1 China Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 8.3 China Therapeutic Radioisotopes Sales Breakdown by Application
  • 8.3.1 China 312 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan Therapeutic Radioisotopes Market Facts & Figures

• 9.1 Japan Therapeutic Radioisotopes Sales by Company
  • 9.1.1 Japan Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 9.1.2 Japan Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 9.2 Japan Therapeutic Radioisotopes Sales Breakdown by Type
  • 9.2.1 Japan Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 9.3 Japan Therapeutic Radioisotopes Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Therapeutic Radioisotopes Market Facts & Figures

• 10.1 Southeast Asia Therapeutic Radioisotopes Sales by Company
  • 10.1.1 Southeast Asia Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 10.2 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type
  • 10.2.1 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Therapeutic Radioisotopes Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Therapeutic Radioisotopes Market Facts & Figures

• 11.1 India Therapeutic Radioisotopes Sales by Company
  • 11.1.1 India Therapeutic Radioisotopes Sales by Company (2016-2021)
  • 11.1.2 India Therapeutic Radioisotopes Revenue by Company (2016-2021)
• 11.2 India Therapeutic Radioisotopes Sales Breakdown by Type
  • 11.2.1 India Therapeutic Radioisotopes Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Therapeutic Radioisotopes Sales Breakdown by Type (2022-2027)
• 11.3 India Therapeutic Radioisotopes Sales Breakdown by Application
  • 11.3.1 India Therapeutic Radioisotopes Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Therapeutic Radioisotopes Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Therapeutic Radioisotopes Business

• 12.1 Bayer
  • 12.1.1 Bayer Corporation Information
  • 12.1.2 Bayer Business Overview
  • 12.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Bayer Therapeutic Radioisotopes Products Offered
  • 12.1.5 Bayer Recent Development
• 12.2 Novartis
  • 12.2.1 Novartis Corporation Information
  • 12.2.2 Novartis Business Overview
  • 12.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Novartis Therapeutic Radioisotopes Products Offered
  • 12.2.5 Novartis Recent Development
• 12.3 China Isotope & Radiation
  • 12.3.1 China Isotope & Radiation Corporation Information
  • 12.3.2 China Isotope & Radiation Business Overview
  • 12.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 China Isotope & Radiation Therapeutic Radioisotopes Products Offered
  • 12.3.5 China Isotope & Radiation Recent Development
• 12.4 Dongcheng
  • 12.4.1 Dongcheng Corporation Information
  • 12.4.2 Dongcheng Business Overview
  • 12.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Dongcheng Therapeutic Radioisotopes Products Offered
  • 12.4.5 Dongcheng Recent Development
• 12.5 Q BioMed
  • 12.5.1 Q BioMed Corporation Information
  • 12.5.2 Q BioMed Business Overview
  • 12.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Q BioMed Therapeutic Radioisotopes Products Offered
  • 12.5.5 Q BioMed Recent Development
• 12.6 Curium Pharmaceuticals
  • 12.6.1 Curium Pharmaceuticals Corporation Information
  • 12.6.2 Curium Pharmaceuticals Business Overview
  • 12.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Products Offered
  • 12.6.5 Curium Pharmaceuticals Recent Development
• 12.7 Jubilant DraxImage
  • 12.7.1 Jubilant DraxImage Corporation Information
  • 12.7.2 Jubilant DraxImage Business Overview
  • 12.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Jubilant DraxImage Therapeutic Radioisotopes Products Offered
  • 12.7.5 Jubilant DraxImage Recent Development
• 12.8 Lantheus
  • 12.8.1 Lantheus Corporation Information
  • 12.8.2 Lantheus Business Overview
  • 12.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Lantheus Therapeutic Radioisotopes Products Offered
  • 12.8.5 Lantheus Recent Development
• 12.9 Spectrum Pharmaceuticals
  • 12.9.1 Spectrum Pharmaceuticals Corporation Information
  • 12.9.2 Spectrum Pharmaceuticals Business Overview
  • 12.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Products Offered
  • 12.9.5 Spectrum Pharmaceuticals Recent Development
• 12.10 Progenics Pharmaceuticals
  • 12.10.1 Progenics Pharmaceuticals Corporation Information
  • 12.10.2 Progenics Pharmaceuticals Business Overview
  • 12.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Products Offered
  • 12.10.5 Progenics Pharmaceuticals Recent Development
• 12.11 International Isotopes
  • 12.11.1 International Isotopes Corporation Information
  • 12.11.2 International Isotopes Business Overview
  • 12.11.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 International Isotopes Therapeutic Radioisotopes Products Offered
  • 12.11.5 International Isotopes Recent Development

13 Therapeutic Radioisotopes Manufacturing Cost Analysis

• 13.1 Therapeutic Radioisotopes Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Therapeutic Radioisotopes
• 13.4 Therapeutic Radioisotopes Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Therapeutic Radioisotopes Distributors List
• 14.3 Therapeutic Radioisotopes Customers

15 Market Dynamics

• 15.1 Therapeutic Radioisotopes Market Trends
• 15.2 Therapeutic Radioisotopes Drivers
• 15.3 Therapeutic Radioisotopes Market Challenges
• 15.4 Therapeutic Radioisotopes Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List